Plasmodium falciparum Plasmepsin V (PfPMV): Insights into recombinant expression, substrate specificity and active

Nonlawat Boonyalai1, Pichamon Sittikul2, Jirundon Yuvaniyama3

  • 1Department of Biochemistry and Special Research Unit for Protein Engineering and Protein Bioinformatics, Faculty of Science, Kasetsart University, 50 Ngam Wong Wan road, Lat Yao, Chatuchak, Bangkok 10900, Thailand; Center of Excellence for Innovation in Chemistry, Faculty of Science, Kasetsart University, 50 Ngam Wong Wan road, Lat Yao, Chatuchak, Bangkok 10900, Thailand.

Insights

Plasmepsin V (PfPMV), a key Plasmodium falciparum enzyme for parasite export, was successfully expressed and purified. This research provides crucial insights into PfPMV

Area of Science:

  • Malariology
  • Enzymology
  • Protein Biochemistry

Background:

  • Plasmepsin V (PfPMV) from Plasmodium falciparum cleaves the Plasmodium export element (PEXEL) motif, essential for exporting hundreds of parasite proteins.
  • PfPMV is vital for parasite survival, making it a significant target for antimalarial drug development.

Purpose of the Study:

  • To achieve the first recombinant expression of soluble, active PfPMV.
  • To characterize the substrate specificity and kinetic properties of PfPMV.

Main Methods:

  • Two truncated PfPMV forms were fused to thioredoxin (Trx) and expressed as Trx-PfPMVp37 and Trx-PfPMVm84.
  • Purification involved Ni(2+) affinity chromatography and ATP treatment to remove contaminants.
  • Enzyme activity assays were performed using PEXEL-containing peptides (PfEMP2 and HRPII), and kinetic parameters were determined using the Michaelis-Menten model.

Main Results:

  • Both Trx-PfPMV fusion proteins were successfully purified and shown to be active.
  • Trx-PfPMVm84 exhibited higher hydrolytic activity than Trx-PfPMVp37, with a preference for PfEMP2 over HRPII peptide.
  • Substitutions at the P1' and P2 positions significantly affected enzyme activity, indicating specific substrate recognition.
  • PfPMV activity was inhibited by PMSF and nelfinavir, but not pepstatin A.
  • Kinetic analysis revealed lower Km values for PfPMV compared to previous reports.

Conclusions:

  • The study reports the first successful recombinant expression and purification of active Plasmepsin V.
  • Characterization revealed insights into PfPMV's substrate specificity, particularly at the P2 and P1' positions.
  • Findings contribute to understanding enzyme-substrate interactions and inform antimalarial drug target strategies.